(Q53217119)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413642%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413642%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

0 references

Elaine M Sloand

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413642%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Colin O Wu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413642%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Peter Greenberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413642%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Neal Young

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413642%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

John Barrett

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413642%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

English

0 references

publication date

14 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413642%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Oncology

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413642%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413642%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413642%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

2505-2511

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413642%20AND%20SRC:MED&resulttype=core&format=json

Time-dependent covariates in the Cox proportional-hazards regression model

5 January 2020

cites work

1 reference

12 December 2020

Computing the Cox model for case cohort designs

1 reference

12 December 2020

Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes

1 reference

12 December 2020

Report of an international working group to standardize response criteria for myelodysplastic syndromes.

1 reference

12 December 2020

Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS.

1 reference

12 December 2020

Immunosuppressive therapy for patients with refractory anemia

1 reference

12 December 2020

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

1 reference

12 December 2020

Favourable response to antithymocyte or antilymphocyte globulin in low-risk myelodysplastic syndrome patients with a 'non-clonal' pattern of X-chromosome inactivation in bone marrow cells

1 reference

12 December 2020

Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes

1 reference

12 December 2020

Antithymocyte globulin has limited efficacy and substantial toxicity in unselected anemic patients with myelodysplastic syndrome

1 reference

12 December 2020

Current challenges in therapy of myelodysplastic syndromes

1 reference

12 December 2020

A pilot study of antithymocyte globulin (ATG) in the treatment of patients with 'low-risk' myelodysplasia

1 reference

12 December 2020

A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome

1 reference

12 December 2020

Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes

1 reference

12 December 2020

A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes

1 reference

12 December 2020

The effects of 5-aza-2'-deoxycytidine (Decitabine) on the platelet count in patients with intermediate and high-risk myelodysplastic syndromes

1 reference

12 December 2020

Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia

1 reference

12 December 2020

DNA methyltransferase inhibitors in myelodysplastic syndrome

1 reference

12 December 2020

Myelodysplastic syndromes.

1 reference

12 December 2020

Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation.

1 reference

12 December 2020

Myelodysplastic syndromes--coping with ineffective hematopoiesis

1 reference

12 December 2020

Efficacy of lenalidomide in myelodysplastic syndromes

1 reference

12 December 2020

Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF.

1 reference

12 December 2020

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

1 reference

12 December 2020

Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes

1 reference

12 December 2020

Low IPSS score and bone marrow hypocellularity in MDS patients predict hematological responses to antithymocyte globulin

1 reference

12 December 2020

Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome.

1 reference

12 December 2020

Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group

1 reference

12 December 2020

Antilymphocyte globulin for myelodysplastic syndrome

1 reference

12 December 2020

Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan.

1 reference

12 December 2020

International scoring system for evaluating prognosis in myelodysplastic syndromes

1 reference

12 December 2020

Immunosuppressive therapy for hypoplastic myelodysplastic syndrome

1 reference

12 December 2020

Antithymocyte globulin for patients with myelodysplastic syndrome

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2007.11.9214

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413642%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413642%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

PubMed publication ID

18413642

1 reference